In recent years, GLP-1 medications for weight loss have surged in popularity, not only for shedding pounds but also for lowering blood pressure, reducing heart disease risk, improving liver health, and treating sleep apnea. Now, a new potential benefit has emerged: a lower risk of cancer.
Study Findings on GLP-1s and Breast Cancer
A study published in JCO Oncology Practice found that women classified as overweight who use GLP-1 drugs have a reduced chance of developing breast cancer. The study defined overweight as a body mass index (BMI) of 25 or higher.
Researchers at Penn Medicine analyzed breast imaging and medical records of 111,646 women aged 45 to 80 with a BMI of 25 or above. The median age was 61. About 13% of the women had a prescription for a GLP-1 medication. The results showed that those taking GLP-1s had a 30% lower risk of developing breast cancer.
Limitations and Future Research
The study did not account for how long participants had been on GLP-1s or which specific medication they used. Individual genetic breast cancer risk factors were also not considered. It remains unclear whether the same results would apply to women with a lower BMI. Further research is needed to explore the link between GLP-1 use and breast cancer risk.
Lead study author Dr. Elizabeth McDonald stated, "While our study was observational and does not definitively confirm an association between GLP-1 medications and reduced breast cancer incidence, it does add to the growing body of evidence suggesting that it’s worth investigating these weight-loss drugs as potential cancer prevention tools."
Why GLP-1s May Lower Cancer Risk
GLP-1 medications facilitate weight loss, and obesity is a known cancer risk factor. However, the exact mechanisms are not fully understood. Experts have several theories:
- Obesity, particularly after menopause, is a risk factor for breast cancer. Maintaining a healthy weight can reduce cancer risk. The average age of menopause in the U.S. is 52, which falls within the study's age range.
- GLP-1s reduce inflammation in the body, and there is a suspected link between inflammation and breast cancer, according to the Penn Medicine press release.
Breast Cancer Risk Factors and Screening
Additional breast cancer risk factors include older age, dense breasts, genetic mutations like BRCA, family history, alcohol consumption, and lack of physical activity. Knowing the signs and following screening guidelines are crucial for early detection.
Common Signs of Breast Cancer
- A lump in the breast or armpit
- Dimpling of the skin
- Changes to the nipple
- Nipple discharge
- Changes to the skin of the breast
If any concerning symptoms arise, consult a doctor promptly.
Reducing Your Risk
While some factors are beyond control, steps like maintaining a healthy diet, a healthy weight, and regular exercise can help lower risk. Adhering to breast cancer screening guidelines is also vital. The most common screening test is a mammogram, an X-ray of the breast. For average-risk individuals, mammograms typically start at age 40. Those at higher risk may be eligible for earlier or additional screenings.
